These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7670956)

  • 21. Biochemical characterization of the three major subclasses of lipoprotein A-I preparatively isolated from human plasma.
    Duverger N; Rader D; Duchateau P; Fruchart JC; Castro G; Brewer HB
    Biochemistry; 1993 Nov; 32(46):12372-9. PubMed ID: 8241125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scavenger receptor BI (SR-BI) mediates a higher selective cholesteryl ester uptake from LpA-I compared with LpA-I:A-II lipoprotein particles.
    Rinninger F; Brundert M; Budzinski RM; Fruchart JC; Greten H; Castro GR
    Atherosclerosis; 2003 Jan; 166(1):31-40. PubMed ID: 12482548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.
    Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE
    Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
    Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
    Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between low-density lipoprotein size and apolipoprotein A-I-containing particles: the ECTIM study.
    Luc G; Bard JM; Poulain P; Arveiler D; Evans AE; Cambien F; Fruchart JC; Ducimetière P
    Eur J Clin Invest; 1997 Mar; 27(3):242-7. PubMed ID: 9088861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of genotype and diet on cholesterol efflux into plasma and lipoproteins of normal, apolipoprotein A-I-, and apolipoprotein E-deficient mice.
    Huang Y; Zhu Y; Langer C; Raabe M; Wu S; Wiesenhütter B; Seedorf U; Maeda N; Assmann G; von Eckardstein A
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2010-9. PubMed ID: 9351366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
    Ohta T; Ikeda Y; Hattori S; Matsuda I
    Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of high-density apolipoprotein particles A-I and A-I:A-II isolated from humans with cholesteryl ester transfer protein deficiency.
    Duverger N; Rader D; Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Nagano M; Nakamura H; Brewer HB
    Eur J Biochem; 1995 Jan; 227(1-2):123-9. PubMed ID: 7851377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease.
    O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Holmes D; Kottke BA
    Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):228-31. PubMed ID: 7749830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol esters selectively delivered in vivo by high-density-lipoprotein subclass LpA-I to rat liver are processed faster into bile acids than are LpA-I/A-II-derived cholesterol esters.
    Pieters MN; Castro GR; Schouten D; Duchateau P; Fruchart JC; Van Berkel TJ
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):819-23. PubMed ID: 8318010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins A-I and A-II.
    Jones RJ; Owens D; Brennan C; Collins PB; Johnson AH; Tomkin GH
    Atherosclerosis; 1996 Jan; 119(2):151-7. PubMed ID: 8808492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific phospholipid association with apolipoprotein A-I stimulates cholesterol efflux from human fibroblasts. Studies with reconstituted sonicated lipoproteins.
    Zhao Y; Sparks DL; Marcel YL
    J Biol Chem; 1996 Oct; 271(41):25145-51. PubMed ID: 8810270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics.
    Ji J; Watts GF; Johnson AG; Chan DC; Ooi EM; Rye KA; Serone AP; Barrett PH
    J Clin Endocrinol Metab; 2006 Mar; 91(3):973-9. PubMed ID: 16368749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux.
    Czarnecka H; Yokoyama S
    Biochemistry; 1995 Apr; 34(13):4385-92. PubMed ID: 7703252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of high-density lipoprotein particles containing apo A-I, with or without apo A-II, on intracellular cholesterol efflux.
    Oikawa S; Mendez AJ; Oram JF; Bierman EL; Cheung MC
    Biochim Biophys Acta; 1993 Jan; 1165(3):327-34. PubMed ID: 8418891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
    Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients.
    Brites FD; Cavallero E; de Geitere C; Nicolaïew N; Jacotot B; Rosseneu M; Fruchart JC; Wikinski RL; Castro GR
    Clin Chim Acta; 1999 Jan; 279(1-2):1-14. PubMed ID: 10064113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies.
    Segrest JP; Cheung MC; Jones MK
    J Lipid Res; 2013 Oct; 54(10):2733-44. PubMed ID: 23883582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein A-I-containing particles and reverse cholesterol transport: evidence for connection between cholesterol efflux and atherosclerosis risk.
    Fruchart JC; De Geteire C; Delfly B; Castro GR
    Atherosclerosis; 1994 Oct; 110 Suppl():S35-9. PubMed ID: 7857382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.